- Home
- EIG vs JANX Comparison
EIG vs JANX Comparison
Compare EIG & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EIG
- JANX
- Stock Information
- Founded
- EIG 2000
- JANX 2017
- Country
- EIG United States
- JANX United States
- Employees
- EIG N/A
- JANX N/A
- Industry
- EIG Property-Casualty Insurers
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- EIG Finance
- JANX Health Care
- Exchange
- EIG Nasdaq
- JANX Nasdaq
- Market Cap
- EIG 1.1B
- JANX 1.4B
- IPO Year
- EIG 2007
- JANX 2021
- Fundamental
- Price
- EIG $46.22
- JANX $25.15
- Analyst Decision
- EIG Strong Buy
- JANX Strong Buy
- Analyst Count
- EIG 1
- JANX 8
- Target Price
- EIG $58.00
- JANX $90.63
- AVG Volume (30 Days)
- EIG 173.2K
- JANX 711.6K
- Earning Date
- EIG 07-30-2025
- JANX 08-06-2025
- Dividend Yield
- EIG 2.77%
- JANX N/A
- EPS Growth
- EIG N/A
- JANX N/A
- EPS
- EIG 4.13
- JANX N/A
- Revenue
- EIG $860,200,000.00
- JANX $9,336,000.00
- Revenue This Year
- EIG N/A
- JANX N/A
- Revenue Next Year
- EIG $3.61
- JANX $1,470.82
- P/E Ratio
- EIG $11.20
- JANX N/A
- Revenue Growth
- EIG N/A
- JANX 28.12
- 52 Week Low
- EIG $42.82
- JANX $22.48
- 52 Week High
- EIG $54.44
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- EIG 41.73
- JANX 54.41
- Support Level
- EIG $46.43
- JANX $23.52
- Resistance Level
- EIG $47.91
- JANX $24.87
- Average True Range (ATR)
- EIG 0.78
- JANX 1.13
- MACD
- EIG -0.02
- JANX 0.33
- Stochastic Oscillator
- EIG 15.69
- JANX 70.90
About EIG Employers Holdings Inc
Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.